Re: Muste et al.: Outcomes and complications of pars plana vitrectomy for nonclearing vitreous hemorrhage without tractional elements (Ophthalmology Retina. 2026;10:596–605)
Re: Muste et al.: Outcomes and complications of pars plana vitrectomy for nonclearing vitreous hemorrhage without tractional elements (Ophthalmology Retina. 2026;10:596–605). // Ophthalmology Retina. – URL: https://www.sciencedirect.com/science/article/pii/S2468653026003933?dgcid=rss_sd_all
Re: Muste et al.: Outcomes and complications of pars plana vitrectomy for nonclearing vitreous hemorrhage without tractional elements (Ophthalmology Retina. 2026;10:596–605). Ophthalmology Retina. https://www.sciencedirect.com/science/article/pii/S2468653026003933?dgcid=rss_sd_all
“Re: Muste et al.: Outcomes and complications of pars plana vitrectomy for nonclearing vitreous hemorrhage without tractional elements (Ophthalmology Retina. 2026;10:596–605).” Ophthalmology Retina.
@article{article60982,
title = {Re: Muste et al.: Outcomes and complications of pars plana vitrectomy for nonclearing vitreous hemorrhage without tractional elements (Ophthalmology Retina. 2026;10:596–605)},
journal = {Ophthalmology Retina},
url = {https://www.sciencedirect.com/science/article/pii/S2468653026003933?dgcid=rss_sd_all}
}
Abstract Purpose To compare the efficacy of intravitreal dexamethasone (DEX) implant‐based regimen versus ranibizumab‐based regimen for managing retinal exudation and complications in stage 3 Coats' disease. Methods Thirty‐seven eyes...
Abstract Foundation models are rapidly emerging as a major development in ophthalmic artificial intelligence, largely because they can achieve strong downstream performance with fewer labelled images than conventional supervised models,...
Abstract Purpose To evaluate intraretinal fluid (IRF) volume dynamics after switching from aflibercept 2 mg to faricimab in eyes with diabetic macular oedema (DME), stratified by prior response to aflibercept. Methods This retrospective...